|Bid||9.20 x 2900|
|Ask||9.19 x 1800|
|Day's Range||8.73 - 9.26|
|52 Week Range||2.20 - 9.26|
|Beta (5Y Monthly)||2.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.25|
Pacific Biosciences (PACB) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
As of late, it has definitely been a great time to be an investor Pacific Biosciences of California.
Gene sequencing company Illumina Inc is in late talks to buy cancer testing startup Grail Inc, Bloomberg News reported on Wednesday, citing people familiar with the matter. Grail could fetch more than the $6 billion valuation that it had reached from previous fundraisings, the report https://www.bloomberg.com/news/articles/2020-09-16/illumina-said-to-be-in-talks-to-buy-health-care-startup-grail?sref=vEQJzSks said, adding the companies could announce a deal as soon as this week. Both Illumina and Grail did not immediately respond to Reuters requests for comment.